Abstract: This invention relates to novel compounds having the structural formula (I) below: [Chemical formula should be inserted here. Please see paper copy] and to their pharmaceutically acceptable salt, compositions and methods of use. These novel compounds provide a treatment or prophylaxis of cognitive impairment, Alzheimer Disease, neurodegeneration and dementia.
Type:
Application
Filed:
April 4, 2007
Publication date:
April 16, 2009
Applicants:
ASTEX THERAPEUTICS LTD., ASTRAECA AB
Inventors:
Stefan Berg, Johan Hedstrom, Sven Hellberg, Johan Malmberg